STEPHEN DAVIS - 01 Sep 2022 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
Director
Signature
/s/ Stephen R. Davis
Issuer symbol
N/A
Transactions as of
01 Sep 2022
Net transactions value
$0
Form type
4
Filing time
02 Sep 2022, 10:30:17 UTC
Previous filing
16 Jun 2022
Next filing
18 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLCM Common Stock Options Exercise $0 +43,400 +232% $0.000000 62,115 01 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on September 1, 2023, the one-year anniversary of the grant date.